MCID: RHM014
MIFTS: 42

Rheumatoid Vasculitis malady

Categories: Rare diseases, Bone diseases, Cardiovascular diseases

Aliases & Classifications for Rheumatoid Vasculitis

Aliases & Descriptions for Rheumatoid Vasculitis:

Name: Rheumatoid Vasculitis 50 52 69

Classifications:



External Ids:

ICD10 33 M05.2

Summaries for Rheumatoid Vasculitis

MalaCards based summary : Rheumatoid Vasculitis is related to rheumatoid arthritis and myocardial infarction. An important gene associated with Rheumatoid Vasculitis is SELE (Selectin E), and among its related pathways/superpathways are Interferon gamma signaling and Development VEGF signaling via VEGFR2 - generic cascades. The drugs Glatiramer Acetate and Vaccines have been mentioned in the context of this disorder. Affiliated tissues include skin, liver and endothelial, and related phenotypes are cellular and hematopoietic system

Wikipedia : 71 Rheumatoid vasculitis is skin condition that is a typical feature of rheumatoid arthritis, presenting as... more...

Related Diseases for Rheumatoid Vasculitis

Diseases related to Rheumatoid Vasculitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 88)
id Related Disease Score Top Affiliating Genes
1 rheumatoid arthritis 29.8 HLA-DRB1 ICAM1 MIF TNF VCAM1
2 myocardial infarction 29.3 ICAM1 REN SELE TNF VCAM1
3 vasculitis 10.6
4 hypotrichosis-lymphedema-telangiectasia-renal defect syndrome 10.3 SELE TNF
5 tonsil cancer 10.3 ICAM1 SELE
6 tick paralysis 10.2 ICAM1 SELE
7 urethral intrinsic sphincter deficiency 10.2 SELE TNF
8 bilateral parasagittal parieto-occipital polymicrogyria 10.2 HLA-DRB1 TNF
9 mirizzi syndrome 10.2 HLA-DRB1 TNF
10 autosomal dominant intermediate charcot-marie-tooth 10.2 HLA-DRB1 TNF
11 distal trisomy 14q 10.2 HLA-DRB1 TNF
12 swine influenza 10.2 HLA-DRB1 TNF
13 angiomatosis, diffuse corticomeningeal, of divry and van bogaert 10.2 HLA-DRB1 TNF
14 hirschsprung disease 7 10.2 SELE VCAM1
15 dermatomycosis 10.2 ICAM1 SELE TNF
16 kernicterus due to isoimmunization 10.2 HLA-DRB1 TNF
17 powassan encephalitis 10.2 ICAM1 SELE TNF
18 dracunculiasis 10.2 ICAM1 SELE TNF
19 balkan nephropathy 10.2 ICAM1 SELE TNF
20 ependymoblastoma 10.2 ICAM1 VCAM1
21 parasitic protozoa infectious disease 10.2 ICAM1 SELE TNF
22 human immunodeficiency virus infectious disease 10.2 HLA-DRB1 TNF
23 hypopyon ulcer 10.2 ICAM1 SELE VCAM1
24 macrodactyly of the foot 10.2 ICAM1 SELE VCAM1
25 persistent mullerian duct syndrome 10.2 ICAM1 TNF VCAM1
26 periosteal chondrosarcoma 10.2 ICAM1 SELE VCAM1
27 phlegmonous dacryocystitis 10.2 ICAM1 SELE VCAM1
28 craniopharyngioma 10.2 ICAM1 SELE VCAM1
29 pigmentation disease 10.1 ICAM1 TNF VCAM1
30 brown's tendon sheath syndrome 10.1 ICAM1 TNF VCAM1
31 pyelonephritis 10.1 ICAM1 REN TNF
32 hypotrichosis 4 10.1 ICAM1 TNF
33 chromoblastomycosis 10.1 ICAM1 TNF
34 limb ischemia 10.1 ICAM1 REN TNF
35 diabetic encephalopathy 10.1 ICAM1 REN TNF
36 myelophthisic anemia 10.1 ICAM1 SELE VCAM1
37 peripheral artery disease 10.1 HLA-DRB1 TNF VCAM1
38 molybdenum cofactor deficiency a 10.1 HLA-DRB1 SELE TNF
39 heart valve disease 10.1 ICAM1 MIF VCAM1
40 clostridium difficile colitis 10.1 HLA-DRB1 TNF
41 linear lichen planus 10.1 CD44 HLA-DRB1
42 respiratory system disease 10.1 HLA-DRB1 TNF VCAM1
43 lymph node disease 10.1 CD44 ICAM1 SELE
44 sparganosis 10.1 ICAM1 SELE
45 intracranial hemorrhage in brain cerebrovascular malformations 10.1 HLA-DRB1 MIF TNF
46 erb-duchenne and dejerine-klumpke palsies 10.1 ICAM1 SELE TNF VCAM1
47 synovium cancer 10.1 ICAM1 SELE TNF VCAM1
48 bare lymphocyte syndrome, type i 10.1 ICAM1 SELE TNF VCAM1
49 eating disorder 10.1 ICAM1 SELE TNF VCAM1
50 geniculate ganglionitis 10.0 ICAM1 MIF SELE TNF

Graphical network of the top 20 diseases related to Rheumatoid Vasculitis:



Diseases related to Rheumatoid Vasculitis

Symptoms & Phenotypes for Rheumatoid Vasculitis

MGI Mouse Phenotypes related to Rheumatoid Vasculitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.02 CD44 CX3CL1 ICAM1 LTF MIF SELE
2 hematopoietic system MP:0005397 10.02 CD44 CX3CL1 ICAM1 LTF MIF REN
3 cardiovascular system MP:0005385 10.01 CD44 CX3CL1 ICAM1 REN SELE SRF
4 homeostasis/metabolism MP:0005376 9.96 CD44 CX3CL1 ICAM1 LTF MIF REN
5 immune system MP:0005387 9.85 VCAM1 CD44 CX3CL1 ICAM1 LTF MIF
6 neoplasm MP:0002006 9.35 ICAM1 LTF MIF TNF CD44
7 normal MP:0002873 9.1 SELE SRF CD44 LTF MIF REN

Drugs & Therapeutics for Rheumatoid Vasculitis

Drugs for Rheumatoid Vasculitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 78)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Glatiramer Acetate Approved, Investigational Phase 4 147245-92-9 3081884
2 Vaccines Phase 4
3 Immunosuppressive Agents Phase 4,Phase 2
4 Antirheumatic Agents Phase 4,Phase 2
5 Adjuvants, Immunologic Phase 4
6 Omega 3 Fatty Acid Nutraceutical Phase 4
7
Prednisolone Approved, Vet_approved Phase 2, Phase 3 50-24-8 5755
8
Methylprednisolone Approved, Vet_approved Phase 2, Phase 3 83-43-2 6741
9
Prednisone Approved, Vet_approved Phase 2, Phase 3 53-03-2 5865
10
Alendronate Approved Phase 2, Phase 3 121268-17-5, 66376-36-1 2088
11
Alfacalcidol Approved, Nutraceutical Phase 3 41294-56-8 5282181
12 Prednisolone acetate Phase 2, Phase 3
13 glucocorticoids Phase 2, Phase 3, Phase 1
14 Gastrointestinal Agents Phase 2, Phase 3
15 Neuroprotective Agents Phase 2, Phase 3
16 Hormone Antagonists Phase 2, Phase 3, Phase 1
17 Hormones Phase 2, Phase 3, Phase 1
18 Peripheral Nervous System Agents Phase 2, Phase 3
19 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 2, Phase 3, Phase 1
20 Prednisolone hemisuccinate Phase 2, Phase 3
21 Prednisolone phosphate Phase 2, Phase 3
22 Protective Agents Phase 2, Phase 3
23 Antiemetics Phase 2, Phase 3
24 Anti-Inflammatory Agents Phase 2, Phase 3
25 Methylprednisolone acetate Phase 2, Phase 3
26 Methylprednisolone Hemisuccinate Phase 2, Phase 3
27 Autonomic Agents Phase 2, Phase 3
28 Antineoplastic Agents, Hormonal Phase 2, Phase 3
29 vitamin d Phase 3
30 Trace Elements Phase 3
31 Hydroxycholecalciferols Phase 3
32 Vitamins Phase 3
33 Micronutrients Phase 3
34 Bone Density Conservation Agents Phase 2, Phase 3, Phase 1
35 Pharmaceutical Solutions Phase 3
36
Methotrexate Approved Phase 2 1959-05-2, 59-05-2 126941
37
Etanercept Approved, Investigational Phase 2 185243-69-0
38
alemtuzumab Approved, Investigational Phase 2 216503-57-0
39
rituximab Approved Phase 2 174722-31-7 10201696
40
Aldesleukin Approved Phase 2 85898-30-2, 110942-02-4
41
Hydroxychloroquine Approved Phase 2 118-42-3 3652
42
Denosumab Approved Phase 1, Phase 2 615258-40-7
43 Immunoglobulins Phase 2,Phase 1
44 Anti-Infective Agents Phase 2
45 Antibodies Phase 2,Phase 1
46 Analgesics Phase 2
47 Analgesics, Non-Narcotic Phase 2
48 Antibodies, Monoclonal Phase 2
49 Anti-Inflammatory Agents, Non-Steroidal Phase 2
50 Interleukin-2 Phase 2

Interventional clinical trials:

(show all 35)
id Name Status NCT ID Phase
1 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
2 Glatiramer Acetate for Multiple Sclerosis With Autoimmune Comorbidities Completed NCT01456416 Phase 4
3 Trial to Study the Effects of Supplementary Omega-3 on Serum C-Reactive Protein Levels Terminated NCT00578578 Phase 4
4 Alendronate Osteoporosis Study Completed NCT00277251 Phase 2, Phase 3
5 Timed Release Tablet Prednisone in Polymyalgia Rheumatica Completed NCT00836810 Phase 2, Phase 3
6 Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol. Completed NCT00138983 Phase 3
7 Safety and Efficacy of tocilizuMAb Versus Placebo in Polymyalgia rHeumatica With glucocORticoid dEpendence SEMAPHORE Recruiting NCT02908217 Phase 3
8 Etanercept to Treat Wegener's Granulomatosis Completed NCT00001901 Phase 2
9 Alemtuzumab to Treat Sporadic Inclusion Body Myositis Completed NCT00079768 Phase 2
10 Study of Tocilizumab to Treat Polymyalgia Rheumatica Completed NCT01396317 Phase 2
11 Rituximab Objective Outcome Measures Trial in SLE Recruiting NCT03054259 Phase 2
12 Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases Recruiting NCT01988506 Phase 2
13 Study of Anti-Malarials in Incomplete Lupus Erythematosus Not yet recruiting NCT03030118 Phase 2
14 Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders Not yet recruiting NCT02418273 Phase 1, Phase 2
15 Infections and Autoimmunity: Autobodies Screening in Multiple Sclerosis Unknown status NCT00230204 Phase 1
16 Stem Cell Support in Patients With Rheumatoid Arthritis Terminated NCT00278551 Phase 1
17 the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients Unknown status NCT02381587
18 Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases Unknown status NCT00006055
19 Immunogenicity and Safety of Vaccinations in Immunocompromised Persons Completed NCT01947465
20 Evaluation and Management of Cardiovascular Risk Factors in Inflammatory and Acquired Dysimmune Diseases (CARMIN) Completed NCT02835547
21 Resistance Exercise in Rheumatic Disease Recruiting NCT01599260
22 Phenomics in Autoimmune and Inflammatory Diseases Recruiting NCT02466217
23 Prevalence and Early Markers of Atherosclerosis in Adults With a History of Kawasaki Disease Recruiting NCT01440075
24 Pregnancy and Medically Assisted Conception in Rare Diseases Recruiting NCT02450396
25 Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin Diseases Recruiting NCT01952275
26 Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases Recruiting NCT02925351
27 Exercise in Sjogren, Myositis and Takayasu's Arteritis Recruiting NCT01501019
28 Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford Recruiting NCT01793168
29 Measurement of Antibodies in Adults With a History of Kawasaki Disease Active, not recruiting NCT02853266
30 Protocol For The Quantitation Of Pain In The Diagnosis Of Polymyalgia Rheumatica Active, not recruiting NCT00847236
31 JOURNEY II XR Safety and Effectiveness PMCF Not yet recruiting NCT03136887
32 Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases? Not yet recruiting NCT02498808
33 VCRC Longitudinal Protocol for Aortitis Not yet recruiting NCT03022331
34 Study of the Role of Soluble Forms of RAGE (sRAGE/esRAGE) as Diagnostic and Prognostic Biomarkers of Systemic Lupus Erythematosus. Not yet recruiting NCT02891213
35 99m-Technetium- Glucosamine in Arthritis No longer available NCT01789151

Search NIH Clinical Center for Rheumatoid Vasculitis

Genetic Tests for Rheumatoid Vasculitis

Anatomical Context for Rheumatoid Vasculitis

MalaCards organs/tissues related to Rheumatoid Vasculitis:

39
Skin, Liver, Endothelial, Salivary Gland, Neutrophil, Retina, Bone

Publications for Rheumatoid Vasculitis

Articles related to Rheumatoid Vasculitis:

(show top 50) (show all 136)
id Title Authors Year
1
Refractory rheumatoid vasculitis-a therapeutic dilemma. ( 28031846 )
2016
2
A case of rheumatoid vasculitis. ( 27037329 )
2016
3
Methotrexate-associated EBV-positive vasculitis in the skin: a report of two cases simulating rheumatoid vasculitis. ( 26955985 )
2016
4
Poster 94 Mononeuritis Multiplex Secondary to HCV Cryoglobulinemia and Rheumatoid Vasculitis: A Case Report. ( 27672862 )
2016
5
A case of rheumatoid vasculitis with acquired reactive perforating collagenosis. ( 27846744 )
2016
6
Rheumatoid vasculitis: early presentation of rheumatoid arthritis. ( 27873751 )
2016
7
Refractory rheumatoid vasculitis. ( 28031844 )
2016
8
New onset of rheumatoid vasculitis during abatacept therapy and subsequent improvement after rituximab. ( 27052429 )
2016
9
Recurrent Stenosis of the Ileum Caused by Rheumatoid Vasculitis. ( 27041172 )
2016
10
The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis. ( 26106958 )
2015
11
Toxic epidermal necrolysis due to therapy with cyclophosphamide and mesna : A case report of a patient with seronegative rheumatoid arthritis and rheumatoid vasculitis. ( 26555550 )
2015
12
Rheumatoid vasculitis - Case report. ( 25772654 )
2015
13
Rheumatoid Vasculitis. ( 26278313 )
2015
14
The dramatic effect of dapsone on cutaneous bullous and pustular rheumatoid vasculitis on the sole. ( 25865233 )
2015
15
Rheumatoid vasculitis: going, going, but not yet gone. ( 25952359 )
2015
16
New insight into the rheumatoid vasculitis. ( 26402981 )
2015
17
Rheumatoid arthritis: Rheumatoid vasculitis--down but not out. ( 24595091 )
2014
18
Rheumatoid vasculitis: an update. ( 25405822 )
2014
19
Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis. ( 24533557 )
2014
20
Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. ( 24108586 )
2014
21
Severe gangrene accompanied by varicella zoster virus-related vasculitis mimicking rheumatoid vasculitis. ( 24761143 )
2014
22
Peripheral ulcerative keratitis as the presenting feature of systemic rheumatoid vasculitis without joint involvement. ( 24234515 )
2013
23
Successful treatment of rheumatoid vasculitis-associated skin ulcer with a TNF-I+ antagonist. ( 23557520 )
2013
24
Tocilizumab improves systemic rheumatoid vasculitis with necrotizing crescentic glomerulonephritis. ( 23494445 )
2013
25
Successful treatment of digital tip necrosis in rheumatoid vasculitis with anti-CD20 antibody rituximab. ( 23319024 )
2013
26
Association of HLA-DRB5*01 with protection against cutaneous manifestations of rheumatoid vasculitis in Brazilian patients. ( 22641591 )
2012
27
The rapid efficacy of abatacept in a patient with rheumatoid vasculitis. ( 22124545 )
2012
28
Foot ulcers caused by rheumatoid vasculitis in a patient with rheumatoid arthritis undergoing etanercept treatment. ( 23154729 )
2012
29
Cerebral rheumatoid vasculitis: a case report. ( 22974191 )
2012
30
Elevated serum levels of macrophage migration inhibitory factor and their significant correlation with rheumatoid vasculitis disease activity. ( 21607712 )
2012
31
Case of severe liver damage after the induction of tocilizumab therapy for rheumatoid vasculitis. ( 21435128 )
2011
32
Successful treatment with humanised anti-interleukin 6 receptor antibody for multidrug-refractory and anti-tumour necrosis factor-resistant systemic rheumatoid vasculitis. ( 21385558 )
2011
33
Rheumatoid vasculitis: vanishing menace or target for new treatments? ( 20842467 )
2010
34
Are anti-cyclic citrullinated peptide autoantibodies seromarkers for rheumatoid vasculitis in a cohort of patients with systemic vasculitis? ( 20107034 )
2010
35
Rheumatoid vasculitis of crural muscles confirmed by muscle biopsy in the absence of inflammatory myopathy: histologic and MRI study. ( 19639318 )
2010
36
Decline in rheumatoid vasculitis prevalence among US veterans: a retrospective cross-sectional study. ( 19714622 )
2009
37
Disseminated herpes zoster mimicking rheumatoid vasculitis in a rheumatoid arthritis patient on etanercept. ( 19648728 )
2009
38
Therapeutic effect of argatroban on rheumatoid vasculitis with antiphosphatidylserine-prothrombin complex antibody. ( 18711097 )
2008
39
Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. ( 18411212 )
2008
40
Nasal tip necrosis--an unusual presentation of rheumatoid vasculitis. ( 17318275 )
2007
41
A case of rheumatoid vasculitis involving the gastrointestinal tract in early disease. ( 17908700 )
2007
42
Systemic rheumatoid vasculitis: a review. ( 17023257 )
2006
43
Increased serum levels of soluble fractalkine (CX3CL1) correlate with disease activity in rheumatoid vasculitis. ( 17075825 )
2006
44
Successful treatment of rheumatoid vasculitis-associated foot drop with rituximab. ( 16936329 )
2006
45
Should anti-tumor necrosis factor-alpha be the first therapy for rheumatoid vasculitis? ( 16465676 )
2006
46
Decrease over time in the incidence of systemic rheumatoid vasculitis: Comment on the article by Turesson et al. ( 15880813 )
2005
47
Severe proximal myopathy and mononeuritis multiplex in rheumatoid arthritis: manifestations of rheumatoid vasculitis. ( 16357697 )
2005
48
Rheumatoid vasculitis treated with infliximab. ( 16078342 )
2005
49
Successful treatment of rheumatoid vasculitis-associated foot-drop with infliximab. ( 15801041 )
2005
50
Particular HLA-DRB1 shared epitope genotypes are strongly associated with rheumatoid vasculitis. ( 15529352 )
2004

Variations for Rheumatoid Vasculitis

Expression for Rheumatoid Vasculitis

Search GEO for disease gene expression data for Rheumatoid Vasculitis.

Pathways for Rheumatoid Vasculitis

Pathways related to Rheumatoid Vasculitis according to GeneCards Suite gene sharing:

(show all 24)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
12.33 CD44 HLA-DRB1 ICAM1 VCAM1
2
Show member pathways
12.19 CD44 ICAM1 SELE VCAM1
3 12.17 HLA-DRB1 ICAM1 SRF TNF VCAM1
4 12.1 CD44 HLA-DRB1 ICAM1
5
Show member pathways
12.03 CD44 MIF SELE
6
Show member pathways
11.94 CD44 ICAM1 VCAM1
7 11.92 HLA-DRB1 ICAM1 SELE VCAM1
8 11.88 ICAM1 SELE TNF VCAM1
9 11.84 ICAM1 MIF TNF
10 11.81 ICAM1 TNF VCAM1
11 11.78 CD44 ICAM1 VCAM1
12 11.72 CD44 HLA-DRB1 TNF
13 11.7 ICAM1 TNF VCAM1
14 11.7 ICAM1 SELE TNF VCAM1
15 11.65 HLA-DRB1 ICAM1 TNF
16 11.53 ICAM1 TNF VCAM1
17 11.39 CX3CL1 ICAM1 SELE TNF VCAM1
18 11.31 ICAM1 SELE VCAM1
19 11.25 ICAM1 SELE TNF VCAM1
20 11.09 HLA-DRB1 TNF
21 11 ICAM1 SELE TNF VCAM1
22 10.94 TNF VCAM1
23
Show member pathways
10.82 ICAM1 MIF SELE TNF VCAM1
24 10.7 ICAM1 TNF VCAM1

GO Terms for Rheumatoid Vasculitis

Cellular components related to Rheumatoid Vasculitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 CX3CL1 ICAM1 LTF MIF REN SELE
2 external side of plasma membrane GO:0009897 9.46 HLA-DRB1 ICAM1 TNF VCAM1
3 cell surface GO:0009986 9.23 CD44 CX3CL1 HLA-DRB1 ICAM1 LTF MIF

Biological processes related to Rheumatoid Vasculitis according to GeneCards Suite gene sharing:

(show all 26)
id Name GO ID Score Top Affiliating Genes
1 cell adhesion GO:0007155 9.93 CD44 CX3CL1 ICAM1 SELE VCAM1
2 extracellular matrix organization GO:0030198 9.8 CD44 ICAM1 TNF VCAM1
3 response to hypoxia GO:0001666 9.79 ICAM1 SRF VCAM1
4 positive regulation of NF-kappaB transcription factor activity GO:0051092 9.79 ICAM1 LTF TNF
5 cellular response to tumor necrosis factor GO:0071356 9.77 CX3CL1 ICAM1 VCAM1
6 response to lipopolysaccharide GO:0032496 9.76 ICAM1 REN SELE VCAM1
7 cell-matrix adhesion GO:0007160 9.73 CD44 SRF VCAM1
8 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.72 CD44 ICAM1 MIF
9 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.7 CD44 MIF TNF
10 cell aging GO:0007569 9.63 ICAM1 MIF
11 positive regulation of cytokine secretion GO:0050715 9.62 MIF TNF
12 single organismal cell-cell adhesion GO:0016337 9.62 CD44 ICAM1 SRF VCAM1
13 negative regulation of DNA damage response, signal transduction by p53 class mediator GO:0043518 9.61 CD44 MIF
14 heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules GO:0007157 9.61 ICAM1 SELE VCAM1
15 negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator GO:1902166 9.59 CD44 MIF
16 positive regulation of heterotypic cell-cell adhesion GO:0034116 9.58 CD44 TNF
17 leukocyte migration involved in inflammatory response GO:0002523 9.58 CX3CL1 SELE
18 angiogenesis involved in wound healing GO:0060055 9.57 CX3CL1 SRF
19 leukocyte migration GO:0050900 9.55 CD44 ICAM1 MIF SELE TNF
20 leukocyte cell-cell adhesion GO:0007159 9.54 ICAM1 SELE VCAM1
21 membrane to membrane docking GO:0022614 9.51 ICAM1 VCAM1
22 positive regulation of chemokine (C-X-C motif) ligand 2 production GO:2000343 9.48 MIF TNF
23 leukocyte tethering or rolling GO:0050901 9.43 SELE TNF VCAM1
24 positive regulation of leukocyte adhesion to vascular endothelial cell GO:1904996 9.4 ICAM1 TNF
25 interferon-gamma-mediated signaling pathway GO:0060333 9.26 CD44 HLA-DRB1 ICAM1 VCAM1
26 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.02 CD44 CX3CL1 ICAM1 MIF TNF

Molecular functions related to Rheumatoid Vasculitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.13 CX3CL1 MIF TNF
2 integrin binding GO:0005178 8.8 CX3CL1 ICAM1 VCAM1

Sources for Rheumatoid Vasculitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....